Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion
NCT00247052 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2009-08-03
Summary
The aim of the sudy is to evaluate, through clinical, biological and transthoracic echocardiography follow up, the evolution of post operative (cardiac surgery) pericardial effusion and mostly to evaluate the efficiency of a non steroidal anti inflammatory (NSAID) drug (diclofenac)for this indication.
Conditions
- Pericardial Effusion
Interventions
- DRUG
-
diclofenac
diclofenac 50 mg bid versus placebo bid
- DRUG
-
diclofenac
diclofenac 100 mg per day for 14 days
- DRUG
-
matching placebo
Sponsors & Collaborators
-
CLIPA
collaborator UNKNOWN -
Clinact
collaborator OTHER -
French Cardiology Society
lead OTHER
Principal Investigators
-
Philippe Meurin, MD · Les grands Prés; 27 rue Sainte Christine 77174 , Villeneuve Saint Denis, France
-
Philippe Meurin, MD · Les Grands Prés
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-03-31
- Primary Completion
- 2008-12-31
- Completion
- 2009-02-28
Countries
- France
Study Locations
More Related Trials
-
PHOspholamban RElated CArdiomyopathy STudy - Intervention
NCT01857856 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Colchicine to Prevent the Postpericardiotomy Syndrome
NCT00128427 ·Status: COMPLETED ·Phase: PHASE3
-
Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction
NCT01901809 ·Status: COMPLETED ·Phase: PHASE4
-
Dapagliflozin With or Without Spironolactone for HFpEF
NCT05676684 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Role of Colchicine as Anti-Inflammatory Therapy in HFpEF
NCT06837623 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT00462670 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction
NCT05139615 ·Status: TERMINATED ·Phase: PHASE2
-
Dapagliflozin (DAPA) Effects in HFpEF
NCT04730947 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
NCT00050076 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure
NCT00505336 ·Status: COMPLETED ·Phase: NA
-
Interleukin-1 Blockade in HF With Preserved EF
NCT02173548 ·Status: COMPLETED ·Phase: PHASE2
-
Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction
NCT04475042 ·Status: UNKNOWN ·Phase: PHASE2
-
Cardiometabolic Effects of Dapagliflozin in Heart Failure With Reduced or Mildly Reduced Ejection Fraction
NCT05420285 ·Status: UNKNOWN ·Phase: PHASE2
-
Drainage or Pericardiocentesis (DROP) Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention
NCT01665495 ·Status: UNKNOWN ·Phase: NA
-
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
NCT01151137 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure
NCT01618448 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
NCT06215586 ·Status: COMPLETED ·Phase: PHASE2
-
N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure
NCT00692718 ·Status: UNKNOWN ·Phase: PHASE4
-
Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List
NCT04782245 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)
NCT00525265 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure
NCT04890548 ·Status: WITHDRAWN ·Phase: PHASE1
-
Examining the Effects of Mitochondrial Oxidative Stress in DCM
NCT05410873 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction
NCT05477498 ·Status: WITHDRAWN ·Phase: PHASE4
-
Levosimendan In Ambulatory Heart Failure Patients
NCT04705337 ·Status: TERMINATED ·Phase: PHASE4
-
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
NCT00745316 ·Status: TERMINATED ·Phase: PHASE2